» Articles » PMID: 12242284

E7 Abolishes Raf-induced Arrest Via Mislocalization of P21(Cip1)

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2002 Sep 21
PMID 12242284
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The cellular response to oncogenic Ras depends upon the presence or absence of cooperating mutations. In the absence of immortalizing oncogenes or genetic lesions, activation of the Ras/Raf pathway results in a p21(Cip1)-dependent cellular arrest. The human papillomavirus oncoprotein E7 transforms primary cells in cooperation with Ras and abolishes p21(Cip1)-mediated growth arrest in the presence of various antimitogenic signals. Here we have utilized a conditional Raf molecule to investigate the effects of E7 on p21(Cip1) function in the context of Raf-induced cellular arrest. E7 bypassed Raf-induced arrest and alleviated inhibition of cyclin E-CDK2 without suppressing Raf-specific synthesis of p21(Cip1) or derepressing p21(Cip1)-associated CDK2 complexes. Activation of Raf led to nuclear accumulation of p21(Cip1), and we provide evidence that this effect is mediated by inhibition of Akt, a regulator of p21(Cip1) localization. Loss of Akt activity appears to be an important event in the cellular arrest associated with Raf-induction, since maintenance of Akt activity was necessary and sufficient to bypass Raf-induced arrest. In agreement, expression of E7 sustained Akt activity and reduced nuclear accumulation of p21(Cip1), resulting in decreased association between p21(Cip1) and cyclin E-CDK2. Taken together, these data suggest that E7 inhibits p21(Cip1) function in the context of Raf signaling by altering Raf-Akt antagonism and preventing the proper subcellular localization of p21(Cip1). We propose that E7 elicits a proliferative response to Raf signaling by targeting p21(Cip1) function via a novel mechanism.

Citing Articles

Drugs and drug targets for the treatment of HPV-positive cervical cancer.

Burmeister C, Khan S, Prince S Tumour Virus Res. 2024; 19():200309.

PMID: 39709045 PMC: 11733058. DOI: 10.1016/j.tvr.2024.200309.


Phosphorylated Adapter RNA Export Protein Is Methylated at Lys 381 by an Methyltransferase-like 21C (METTL21C).

Ke M, Yu X, Sun Y, Han S, Wang L, Zhang T Int J Mol Sci. 2024; 25(1).

PMID: 38203316 PMC: 10779018. DOI: 10.3390/ijms25010145.


Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites.

Tomaic V Cancers (Basel). 2016; 8(10).

PMID: 27775564 PMC: 5082385. DOI: 10.3390/cancers8100095.


The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Zhang L, Wu J, Ling M, Zhao L, Zhao K Mol Cancer. 2015; 14:87.

PMID: 26022660 PMC: 4498560. DOI: 10.1186/s12943-015-0361-x.


Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene.

Fan X, Chen J Cell Cycle. 2014; 13(20):3249-59.

PMID: 25485505 PMC: 4614317. DOI: 10.4161/15384101.2014.953879.


References
1.
Hickman E, Bates S, Vousden K . Perturbation of the p53 response by human papillomavirus type 16 E7. J Virol. 1997; 71(5):3710-8. PMC: 191520. DOI: 10.1128/JVI.71.5.3710-3718.1997. View

2.
LaBaer J, Garrett M, Stevenson L, Slingerland J, Sandhu C, Chou H . New functional activities for the p21 family of CDK inhibitors. Genes Dev. 1997; 11(7):847-62. DOI: 10.1101/gad.11.7.847. View

3.
Ruesch M, Laimins L . Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J Virol. 1997; 71(7):5570-8. PMC: 191799. DOI: 10.1128/JVI.71.7.5570-5578.1997. View

4.
Perez-Roger I, Solomon D, Sewing A, Land H . Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene. 1997; 14(20):2373-81. DOI: 10.1038/sj.onc.1201197. View

5.
Sewing A, Wiseman B, Lloyd A, Land H . High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol. 1997; 17(9):5588-97. PMC: 232407. DOI: 10.1128/MCB.17.9.5588. View